These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2680435)

  • 1. S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism.
    Friedel HA; Goa KL; Benfield P
    Drugs; 1989 Sep; 38(3):389-416. PubMed ID: 2680435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: S-adenosyl-L-methionine--a new therapeutic agent in liver disease?
    Osman E; Owen JS; Burroughs AK
    Aliment Pharmacol Ther; 1993 Feb; 7(1):21-8. PubMed ID: 8439634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [S-adenosyl-L-methionine (SAMe) and its use in hepatology].
    Frezza M; Terpin MM; Peri A
    Minerva Gastroenterol Dietol; 1992; 38(3):145-51. PubMed ID: 1299337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies.
    Bressa GM
    Acta Neurol Scand Suppl; 1994; 154():7-14. PubMed ID: 7941964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of S-adenosyl-L-methionine in the treatment of alcoholic liver disease: introduction and summary of the symposium.
    Purohit V; Russo D
    Alcohol; 2002 Jul; 27(3):151-4. PubMed ID: 12163142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease.
    Chawla RK; Bonkovsky HL; Galambos JT
    Drugs; 1990; 40 Suppl 3():98-110. PubMed ID: 2081485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility.
    Anstee QM; Day CP
    J Hepatol; 2012 Nov; 57(5):1097-109. PubMed ID: 22659519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of S-adenosyl-L-methionine in the treatment of liver diseases.
    Lieber CS
    J Hepatol; 1999 Jun; 30(6):1155-9. PubMed ID: 10406198
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ademetionine: the state of the art and future prospects].
    Almasio P; Pagliaro L
    Ann Ital Med Int; 1993 Oct; 8 Suppl():52S-55S. PubMed ID: 8117523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-adenosyl-L-methionine: its role in the treatment of liver disorders.
    Lieber CS
    Am J Clin Nutr; 2002 Nov; 76(5):1183S-7S. PubMed ID: 12418503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropharmacology of S-adenosyl-L-methionine.
    Baldessarini RJ
    Am J Med; 1987 Nov; 83(5A):95-103. PubMed ID: 3318448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of cyclosporine A-induced alterations in biliary secretion by S-adenosyl-L-methionine in rats.
    Fernández E; Galán AI; Morán D; González-Buitrago JM; Muñoz ME; Jiménez R
    J Pharmacol Exp Ther; 1995 Oct; 275(1):442-9. PubMed ID: 7562583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders.
    Bottiglieri T; Hyland K; Reynolds EH
    Drugs; 1994 Aug; 48(2):137-52. PubMed ID: 7527320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence.
    Mischoulon D; Fava M
    Am J Clin Nutr; 2002 Nov; 76(5):1158S-61S. PubMed ID: 12420702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [S-Adenosylmethionine: plasma levels in hepatic cirrhosis and preliminary results of its clinical use in hepatology. Double-blind study].
    Ideo G
    Minerva Med; 1975 May; 66(33):1571-80. PubMed ID: 1095962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-adenosylmethionine metabolism and liver disease.
    Mato JM; Martínez-Chantar ML; Lu SC
    Ann Hepatol; 2013; 12(2):183-9. PubMed ID: 23396728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of exogenous S-adenosyl-L-methionine in patients with liver disease.
    Kaye GL; Blake JC; Burroughs AK
    Drugs; 1990; 40 Suppl 3():124-8. PubMed ID: 2081477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affective disorders and S-adenosylmethionine: a new hypothesis.
    Cantoni GL; Mudd SH; Andreoli V
    Trends Neurosci; 1989 Sep; 12(9):319-24. PubMed ID: 2480671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affective illness and S-adenosyl methionine: a preliminary report.
    Carney MW; Edeh J; Bottiglieri T; Reynolds EM; Toone BK
    Clin Neuropharmacol; 1986; 9(4):379-85. PubMed ID: 2425961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of extrahepatic membrane cholesterol deposition in patients with chronic liver diseases by S-adenosyl-L-methionine.
    Rafique S; Guardascione M; Osman E; Burroughs AK; Owen JS
    Clin Sci (Lond); 1992 Sep; 83(3):353-6. PubMed ID: 1327655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.